These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 18987260
1. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Mihailovic-Stanojevic N, Jovovic D, Miloradovic Z, Grujic-Milanovic J, Jerkic M, Markovic-Lipkovski J. Nephrol Dial Transplant; 2009 Apr; 24(4):1142-50. PubMed ID: 18987260 [Abstract] [Full Text] [Related]
2. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L. Srp Arh Celok Lek; 2002 Apr; 130(3-4):73-80. PubMed ID: 12154518 [Abstract] [Full Text] [Related]
3. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy. Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L. Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753 [Abstract] [Full Text] [Related]
4. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. Baumann M, Janssen BJ, Hermans JJ, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA. J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193 [Abstract] [Full Text] [Related]
7. Exposure to hydrocarbons and renal disease: an experimental animal model. Mutti A, Coccini T, Alinovi R, Toubeau G, Broeckaert F, Bergamaschi E, Mozzoni P, Nonclercq D, Bernard A, Manzo L. Ren Fail; 1999 Jan; 21(3-4):369-85. PubMed ID: 10416216 [Abstract] [Full Text] [Related]
8. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats]. Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W. Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3199-204. PubMed ID: 16405840 [Abstract] [Full Text] [Related]
11. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan. Yu G, Liang X, Xie X, Yang T, Sun M, Zhao S. Chin Med J (Engl); 2002 Sep 30; 115(9):1287-91. PubMed ID: 12411096 [Abstract] [Full Text] [Related]
15. Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging? Baumann M, Bartholome R, Peutz-Kootstra CJ, Smits JF, Struijker-Boudier HA. Am J Hypertens; 2008 Feb 30; 21(2):177-82. PubMed ID: 18188163 [Abstract] [Full Text] [Related]
16. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats. Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N. Regul Pept; 2005 Dec 15; 132(1-3):59-66. PubMed ID: 16229907 [Abstract] [Full Text] [Related]
17. Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats. Djukanovic L, Susic D, Jovanovic D, Varagic J, Jovanovic D, Starcevic A, Kartaljevic G, Bogdanovic G. Isr J Med Sci; 1994 Oct 15; 30(10):742-6. PubMed ID: 7960685 [Abstract] [Full Text] [Related]
19. The effect of diet on simvastatin and losartan enhancement of endothelial function. Bayorh MA, Layas MF, Mann G, Feuerstein GZ, Eatman D. Clin Exp Hypertens; 2007 Jul 15; 29(5):311-25. PubMed ID: 17653966 [Abstract] [Full Text] [Related]
20. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus. Agha A, Bashir K, Anwar E. Nepal Med Coll J; 2007 Jun 15; 9(2):79-83. PubMed ID: 17899953 [Abstract] [Full Text] [Related] Page: [Next] [New Search]